Skip to content
Subscriber Only

Glaxo to Pay $105 Million to Settle Promotion Claims

GlaxoSmithKline Plc, the U.K.’s largest drugmaker, will pay $105 million to settle claims by California, New York and more than 40 other states that it illegally promoted asthma and antidepressant drugs.

The accord announced today prohibits Glaxo from providing incentive payments to salespeople that encourage uses of the drugs not indicated on their labels, and from using paid doctors to promote its products. The agreement covers the asthma drug Advair and two antidepressants, Paxil and Wellbutrin.